Related Experiment Video
Updated: Aug 13, 2026
Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
Published on: August 9, 2013
Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with
Allen Jeremias1, Abdulhay Albirini, Khaled M Ziada
1Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Insights
Elevated creatine kinase-MB (CK-MB) after percutaneous coronary intervention (PCI) predicts increased late mortality in patients with chronic kidney disease. This finding holds true even with renal dysfunction, highlighting CK-MB
Area of Science:
- Cardiology
- Nephrology
- Biomarkers
Background:
- Elevated creatine kinase-MB (CK-MB) post-percutaneous coronary intervention (PCI) is linked to increased mortality in the general population.
- CK-MB elevation can occur in renal disease without myocardial injury, questioning its significance after PCI in renally impaired patients.
Purpose of the Study:
- To investigate the association between elevated CK-MB levels after PCI and late mortality in patients with chronic renal insufficiency.
Main Methods:
- A cohort of 190 consecutive patients with chronic renal insufficiency (serum creatinine ≥2.0 mg/dL) undergoing PCI were analyzed.
- Patients undergoing PCI for acute myocardial infarction or cardiogenic shock were excluded.
- Follow-up was nearly complete (99.4%) at a mean of 24.8 months.
Main Results:
- Postprocedural CK-MB elevation was observed in 19.4% of patients.
- Late mortality was significantly higher in patients with CK-MB elevation (36.4% vs. 17.5%, P=.017).
- CK-MB elevation independently predicted late mortality (HR 2.44, P=.02), along with New York Heart Association class.
Conclusions:
- Postprocedural CK-MB elevation is an independent predictor of late mortality in patients with chronic renal insufficiency undergoing PCI.
- The predictive value of CK-MB elevation persists despite the presence of renal dysfunction.
Background:
Multiple studies have demonstrated a relationship between creatine kinase-MB (CK-MB) elevation after percutaneous coronary intervention (PCI) and increased late mortality within the general population. Because CK-MB is frequently elevated in renal disease even in the absence of myocardial injury, the clinical significance of CK-MB elevation after PCI in patients with renal insufficiency has been questioned.
Methods:
We sought to examine the association between elevated CK-MB after PCI and late mortality in 190 consecutive patients with chronic renal insufficiency (serum creatinine > or =2.0 mg/dL) undergoing PCI at the Cleveland Clinic between January 1997 and March 2000. Of the total group, 20 patients undergoing PCI for acute myocardial infarction, cardiogenic shock, or both were excluded. Follow-up was 99.4% complete at a mean duration of 24.8 +/- 11.2 months (range 5-43 months).
Results:
CK-MB elevation above the upper limit of normal after intervention was detected in 33 patients (19.4%). Baseline characteristics were not significantly different between the CK-MB elevation group and the normal CK-MB group. Late mortality, however, was significantly higher among patients with postprocedural CK-MB elevation (36.4% vs 17.5%, P =.017). Cox proportional hazard model revealed CK-MB elevation as an independent predictor of late mortality (hazard ratio 2.44, 95% CI 1.14-5.24, P =.02), in addition to New York Heart Association class (hazard ratio 1.35, 95% CI 1.05-1.73, P =.02).
Conclusions:
This analysis of patients with chronic renal insufficiency undergoing PCI suggests that postprocedural CK-MB elevation is an independent predictor of late mortality even in the presence of renal dysfunction.
Related Concept Videos
01:25Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:22Acute Kidney Injury I: Introduction
01:29Acute Kidney Injury III: Clinical Manifestations
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention